103 related articles for article (PubMed ID: 7550019)
1. Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands.
Efange SM; Khare AB; Langason RB
Nucl Med Biol; 1995 May; 22(4):437-44. PubMed ID: 7550019
[TBL] [Abstract][Full Text] [Related]
2. Spirovesamicols: conformationally restricted analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol, AH5183) as potential modulators of presynaptic cholinergic function.
Efange SM; Khare AB; Foulon C; Akella SK; Parsons SM
J Med Chem; 1994 Aug; 37(16):2574-82. PubMed ID: 8057300
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and tissue distribution of (m-[125I]iodobenzyl)trozamicol ([125I]MIBT): potential radioligand for mapping central cholinergic innervation.
Efange SM; Michelson RH; Khare AB; Thomas JR
J Med Chem; 1993 Jun; 36(12):1754-60. PubMed ID: 8510103
[TBL] [Abstract][Full Text] [Related]
4. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
Jung YW; Frey KA; Mulholland GK; del Rosario R; Sherman PS; Raffel DM; Van Dort ME; Kuhl DE; Gildersleeve DL; Wieland DM
J Med Chem; 1996 Aug; 39(17):3331-42. PubMed ID: 8765517
[TBL] [Abstract][Full Text] [Related]
5. In vivo characterization of radioiodinated 2-(4-phenylpiperidino)cyclohexanol (vesamicol) analogs: potential radioligand for mapping presynaptic cholinergic neurons.
Shiba K; Mori H; Matsuda H; Tsuji S; Tonami N; Hisada K
Nucl Med Biol; 1995 Aug; 22(6):823-8. PubMed ID: 8535345
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of radioiodinated analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol) as vesamicol-like agent.
Shiba K; Mori H; Matsuda H; Tsuji S; Kuji I; Sumiya H; Kinuya K; Tonami N; Hisada K; Sumiyosi T
Nucl Med Biol; 1995 Feb; 22(2):205-10. PubMed ID: 7767314
[TBL] [Abstract][Full Text] [Related]
7. Radioiodinated (-)-2-[4-(3-iodophenyl) piperidino] cyclohexanol: a potential radioligand for mapping presynaptic cholinergic neurons.
Shiba K; Mori H; Matsuda H; Ichikawa A; Tonami N
Nucl Med Commun; 1996 Jun; 17(6):485-92. PubMed ID: 8822746
[TBL] [Abstract][Full Text] [Related]
8. The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease.
Efange SM; Langason RB; Khare AB; Low WC
Life Sci; 1996; 58(16):1367-74. PubMed ID: 8614294
[TBL] [Abstract][Full Text] [Related]
9. Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor.
Efange SM; Mach RH; Smith CR; Khare AB; Foulon C; Akella SK; Childers SR; Parsons SM
Biochem Pharmacol; 1995 Mar; 49(6):791-7. PubMed ID: 7702637
[TBL] [Abstract][Full Text] [Related]
10. Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding.
Efange SM; Langason RB; Khare AB
J Nucl Med; 1996 Jul; 37(7):1192-7. PubMed ID: 8965197
[TBL] [Abstract][Full Text] [Related]
11. p-[18F]fluorobenzyltrozamicol ([18F]FBT): molecular decomposition- reconstitution approach to vesamicol receptor radioligands for positron emission tomography.
Efange SM; Mach RH; Khare A; Michelson RH; Nowak PA; Evora PH
Appl Radiat Isot; 1994 Apr; 45(4):465-72. PubMed ID: 8186771
[TBL] [Abstract][Full Text] [Related]
12. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K
Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of radioiodinated (-)-m-iodovesamicol in rat cerebral membranes.
Shiba K; Mori H; Ichikawa A; Tonami N
Life Sci; 1996; 59(13):1039-45. PubMed ID: 8809223
[TBL] [Abstract][Full Text] [Related]
14. Radioiodinated 2-hydroxy-3-(4-iodophenyl)-1-(4-phenylpiperidinyl)propane: potential radiotracer for mapping central cholinergic innervation in vitro.
Efange SM; Dutta AK; Michelson RH; Kung HF; Thomas JR; Billings J; Boudreau RJ
Int J Rad Appl Instrum B; 1992 Apr; 19(3):337-48. PubMed ID: 1629023
[TBL] [Abstract][Full Text] [Related]
15. Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.
Pike VW; Halldin C; Nobuhara K; Hiltunen J; Mulligan RS; Swahn CG; Karlsson P; Olsson H; Hume SP; Hirani E; Whalley J; Pilowsky LS; Larsson S; Schnell PO; Ell PJ; Farde L
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1520-8. PubMed ID: 14579092
[TBL] [Abstract][Full Text] [Related]
16. Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand.
Coffeen PR; Efange SM; Haidet GC; McKnite S; Langason RB; Khare AB; Pennington J; Lurie KG
Nucl Med Biol; 1996 Oct; 23(7):923-6. PubMed ID: 8971861
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
Rogers GA; Kornreich WD; Hand K; Parsons SM
Mol Pharmacol; 1993 Sep; 44(3):633-41. PubMed ID: 8371715
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of radiolabeled piperazine derivatives of vesamicol as SPECT agents for cholinergic neurons.
Bando K; Taguchi K; Ginoza Y; Naganuma T; Tanaka Y; Koike K; Takatoku K
Nucl Med Biol; 2001 Apr; 28(3):251-60. PubMed ID: 11323234
[TBL] [Abstract][Full Text] [Related]
19. Effects of systemic administration of 2-(4-phenyl-piperidino)-cyclohexanol (vesamicol) and an organophosphate DDVP on the cholinergic system in brain regions of rats.
Kobayashi H; Watanabe T; Yasufuku T; Suzuki T; Saitoh S; Takeno K
Brain Res Bull; 1997; 43(1):17-23. PubMed ID: 9205789
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labeling of the vesamicol receptor of cholinergic synaptic vesicles.
Rogers GA; Parsons SM
Biochemistry; 1993 Aug; 32(33):8596-601. PubMed ID: 8357803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
